newsfilter
← Latest News
GlobeNewswire·

VectivBio Announces Successful Opening of US IND for Apraglutide for Acute Graft-Versus-Host Disease

-FDA clears IND Application for Apraglutide for Acute Graft-Versus-Host Disease - Dosing of first patient expected in 1Q 2022 - - Interim data anticipated in 2H 2022 - - FDA previously granted orphan drug designation for apraglutide for the prev